Invention Grant
- Patent Title: Inhibitors of 17Beta-hydroxysteroid dehydrogenases type 1 and type 2
-
Application No.: US15109271Application Date: 2015-01-05
-
Publication No.: US09884839B2Publication Date: 2018-02-06
- Inventor: Rolf Hartmann , Martin Frotscher , Ahmed Saad Abdelsamie Ahmed , Emmanuel Bey , Chris J. van Koppen , Sandrine Oberwinkler-Marchais , Carsten Börger , Lorenz Siebenbürger , Victor Hernández Olmos
- Applicant: ElexoPharm GmbH
- Applicant Address: DE Saarbruecken
- Assignee: ElexoPharm GmbH
- Current Assignee: ElexoPharm GmbH
- Current Assignee Address: DE Saarbruecken
- Agency: The Webb Law Firm
- Priority: EP14150140 20140103
- International Application: PCT/EP2015/050062 WO 20150105
- International Announcement: WO2015/101670 WO 20150709
- Main IPC: C07D333/22
- IPC: C07D333/22 ; C07D333/28 ; C07D409/04 ; C07D409/10 ; C07D409/12
Abstract:
Provided herein are non-steroidal 17beta-hydroxysteroid dehydrogenase type 1 and type 2 (17β-HSD1 and 17β-HSD2) inhibitors, their production and use, especially for the treatment and for prophylaxis of hormone-related diseases.
Public/Granted literature
- US20160318895A1 Inhibitors of 17Beta-Hydroxysteroid Dehydrogenases Type 1 and Type 2 Public/Granted day:2016-11-03
Information query
